Archive for August, 2018

  • aside

    Patent approved in the United States for Isofol’s drug candidate arfolitixorin

    The patent now approved in the United States expires in 2037 and covers both the Active Pharmaceutical Ingredient (arfolitixorin hemisulfate),…

    by